Screener
Ginkgo Bioworks DNA Other Income (Expense)
Other Income (Expense) at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Ginkgo Bioworks in its filing.
Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.
The source filing: Ginkgo Bioworks’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:09 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054298
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Loss on equity method investment | (4,673) | — | (4,673) | — |
| Gain (loss) on investments | 1,987 | (229) | 773 | (3,922) |
| Other income (expense), net | 809 | (1,168) | (6,338) | (5,806) |
| Total other income (expense) | 1,355 | 4,686 | (3,410) | 2,436 |
| Loss from continuing operations before income taxes | (57,193) | (53,477) | (133,332) | (136,699) |
| Income tax (benefit) expense | 128 | (283) | 48 | (195) |
| Net loss from continuing operations | $(57,321) | $(53,194) | $(133,380) | $(136,504) |
| Net income (loss) from discontinued operations, net of tax | 10,611 | (7,106) | 4,083 | (14,753) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Ginkgo Bioworks's other income (expense)?
- Ginkgo Bioworks (DNA) reported other income (expense) of $1.36M in Q2 2026.
- How has Ginkgo Bioworks's other income (expense) changed year-over-year?
- Ginkgo Bioworks's other income (expense) decreased by 71.1% year-over-year, from $4.69M to $1.36M.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about Ginkgo Bioworks's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude